Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U937 |
Human histiocytic lymphoma cell line | ATCC CRL-1593.2 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Innate Immunity, Nov 2014; 20: 799 - 815. | ||
U266B1 |
Human multiple myeloma B lymphocyte cell line from peripheral blood | ATCC TIB-196 | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | M. B. Morelli et al., Int. J. Cancer, 2014, 134:2534-2546, DOI:10.1002/ijc.28591 | Link | ||
U266B1 |
Human multiple myeloma B lymphocyte cell line from peripheral blood | ATCC TIB-196 | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | S. Liberati, PhD Thesis, 2014, Sapienza Universita di Roma | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S.-K. Kim et al., Cellular & Molecular Immunology, 2017, 14: 349-359 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Diaz-Moralli et al., Oncotarget, 2016, 7 (32): 51876-51897 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | RNA-Interference | Metafectene | publication | M.-H. Chien et al., Carcinogenesis, Dec 2009; 30: 2005 - 2013 | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | oligonucleotide | Metafectene | publication | L. Zheng et al., J. Leukoc. Biol., Sep 2007; 82: 619 - 629 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | oligonucleotide | DOTAP | publication | M. M. M. Enriquez ez al., PLoSONE13(11):e0206818, doi.org/10.1371/journal.pone.0206818 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | Metafectene | application note | ![]() |
|||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | N. Mukhamedova et al., J. Lipid Res., Nov 2008; 49: 2312 - 2322 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
RPMI |
Human myeloma B lymphocyte cell line from peripheral blood | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | M. B. Morelli et al., Int. J. Cancer, 2014, 134:2534-2546, DOI:10.1002/ijc.28591 | Link | |||
RPMI |
Human myeloma B lymphocyte cell line from peripheral blood | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | S. Liberati, PhD Thesis, 2014, Sapienza Universita di Roma | Link | |||
Raji |
Human B lymphocyte cell line | ATCC CCL-86 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
|||
PBMC |
Human CD8+ T cells isolated from peripheral blood mononuclear cells | Human | immune system | unknown | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
||||
MEC-2 |
Human chronic B cell leukemia cell line | DSMZ ACC500 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | S. W. Hofbauer et al., Cancer Res., Sep 2010; 70: 7336 - 7344 | Link | |
LCL |
Human lymphoblastoid cell line | Human | immune system | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., May 2012; 21: 2181 - 2193 | Link | |||
LBL |
Human lymphoblastoid cells | Human | immune system | unknown | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |||
KG1 |
Human myelogenous leukemia cell line | ATCC CRL-8031 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
|||
KG1 |
Human myelogenous leukemia cell line | ATCC CRL-8031 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | O. N. Kuvardina et al., Blood, Jun 2015; 125: 3570 - 3579 | |||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | E. Kowenz-Leutz et al., EMBO J., Mar 2010; 29: 1105 - 1115 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | N. Courtial et al., PLoS ONE, 2013, 8(9): e76637. doi:10.1371/journal.pone.0076637 | Link |